<?xml version="1.0" encoding="UTF-8"?>
<ack>
 <title>Acknowledgements</title>
 <p>HPTN 071 (PopART) is sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) under Cooperative Agreements UM1-AI068619, UM1-AI068617, and UM1-AI068613, with funding from the U.S. President's Emergency Plan for AIDS Relief (PEPFAR). Additional funding is provided by the International Initiative for Impact Evaluation (3ie) with support from the Bill &amp; Melinda Gates Foundation, as well as by NIAID, the National Institute on Drug Abuse (NIDA) and the National Institute of Mental Health (NIMH), all part of the U.S. National Institutes of Health (NIH).</p>
 <p>RH, SFl, KSa and DM are jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement, which is also part of the EDCTP2 programme supported by the European Union. Grant Ref: MR/R010161/1</p>
 <p>KH acknowledges Centre funding from the UK Medical Research Council and Department for International Development, MRC Centre for Global Infectious Disease Analysis, reference R/R015600/1, and from the National Institute for Health Research Health Protection Research Unit (NIHR HPRU) with Public Health England, Grant/Award Number: HPRU‐2012‐10080.</p>
 <p>SF acknowledges funding from the Imperial College National Institute for Health Research Biomedical Research Centre</p>
 <p>We wish to acknowledge partners in South Africa including PEPFAR partners (Kheth’Impilo, ANOVA Healthcare and the SACTWU Worker Health Program) and City of Cape Town and Western Cape Government department of health colleagues who have worked to implement the HPTN 071 (PopART) trial activities, as well as partners in Zambia including the Zambian</p>
 <p>Ministry of Health, CIDRZ, ZPCT II and JSI. The team further acknowledges the work of the administrative and support teams at the institutions involved in this trial and the hundreds of field staff who delivered the intervention and collected the research data. The team extends its sincere appreciation to the study’s Community Advisory Boards (CABs), in-country Trial Steering/Management Committees, International Advisory Group and Data and Safety Monitoring Board for their oversight and consultation during study conduct.</p>
 <p>The team thanks all the communities and participants which took part in the study, and without whom the work would not have been possible.</p>
 <p>The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the NIAID, NIMH, NIDA, PEPFAR, 3ie, or the Bill &amp; Melinda Gates Foundation.</p>
</ack>
